We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+3.27%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$75.6B
AUM Growth
+$332M
(+0.44%)
Cap. Flow
-$1.48B
Cap. Flow
% of AUM
-1.96%
Top 10 Holdings %
Top 10 Hldgs %
9.2%
Holding
2,306
New
139
Increased
928
Reduced
1,013
Closed
118
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$234M |
| 2 |
eBay
EBAY
|
+$223M |
| 3 |
Walt Disney
DIS
|
+$189M |
| 4 |
Humana
HUM
|
+$184M |
| 5 |
DXC Technology
DXC
|
+$172M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$236M |
| 2 |
Citizens Financial Group
CFG
|
+$157M |
| 3 |
Applied Materials
AMAT
|
+$156M |
| 4 |
Huntsman Corp
HUN
|
+$154M |
| 5 |
STI
SunTrust Banks, Inc.
STI
|
+$151M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.77% |
| 2 | Technology | 16.07% |
| 3 | Industrials | 14.94% |
| 4 | Consumer Discretionary | 12.29% |
| 5 | Healthcare | 11.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
DexCom
DXCM
$31.2B
| $7.09M | 0.01% |
387,688
+90,844
| +31% | +$1.68M |
|
|
LOGM
902
DELISTED
LogMein, Inc.
LOGM
| $7.07M | 0.01% |
67,688
+1,493
| +2% | +$163K |
|
|
SYNH
903
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $7.05M | 0.01% |
120,541
+32,409
| +37% | +$1.68M |
|
904
Genuine Parts
GPC
$18.2B
| $7.04M | 0.01% |
75,909
-9,351
| -11% | -$859K |
|
905
Madison Square Garden
MSGS
$9.51B
| $7.03M | 0.01% |
50,042
+32,984
| +193% | +$4.67M |
|
906
T-Mobile US
TMUS
$190B
| $7.03M | 0.01% |
115,890
-149,637
| -56% | -$9.75M |
|
907
Marriott Vacations Worldwide
VAC
$4.1B
| $6.99M | 0.01% |
59,398
+26,212
| +79% | +$2.96M |
|
908
AutoZone
AZO
$50B
| $6.9M | 0.01% |
12,098
-10,999
| -48% | -$7.16M |
|
|
SVU
909
DELISTED
SUPERVALU Inc.
SVU
| $6.89M | 0.01% |
299,387
+166,521
| +125% | +$4.43M |
|
|
COHR
910
DELISTED
Coherent Inc
COHR
| $6.83M | 0.01% |
30,368
-4,993
| -14% | -$1.15M |
|
911
Rithm Capital
RITM
$5.62B
| $6.78M | 0.01% |
435,450
-25,755
| -6% | -$426K |
|
912
The GEO Group
GEO
$4.11B
| $6.75M | 0.01% |
228,331
+45,854
| +25% | +$1.44M |
|
913
Barrett Business Services
BBSI
$811M
| $6.75M | 0.01% |
471,264
+72,616
| +18% | +$1.04M |
|
|
CAA
914
DELISTED
CalAtlantic Group, Inc.
CAA
| $6.7M | 0.01% |
189,591
+181,535
| +2,253% | +$6.6M |
|
|
ABMD
915
DELISTED
Abiomed Inc
ABMD
| $6.7M | 0.01% |
46,764
-7,973
| -15% | -$1.07M |
|
916
ArcBest
ARCB
$3.13B
| $6.7M | 0.01% |
325,154
+166,714
| +105% | +$3.62M |
|
917
Acco Brands
ACCO
$404M
| $6.55M | 0.01% |
562,624
-148,998
| -21% | -$1.85M |
|
918
Evertec
EVTC
$1.86B
| $6.55M | 0.01% |
378,552
+62,321
| +20% | +$1.02M |
|
919
Zoetis
ZTS
$31.8B
| $6.54M | 0.01% |
104,858
-889
| -0.8% | -$52.5K |
|
920
Regional Management Corp
RM
$299M
| $6.51M | 0.01% |
275,565
+101,320
| +58% | +$2.13M |
|
|
SCHW
921
Charles Schwab
SCHW
$187B
| $6.5M | 0.01% |
151,232
+21,098
| +16% | +$845K |
|
922
Heritage Insurance Holdings
HRTG
$1.01B
| $6.49M | 0.01% |
498,501
-27,664
| -5% | -$346K |
|
923
Orthofix Medical
OFIX
$421M
| $6.49M | 0.01% |
139,542
-9,751
| -7% | -$405K |
|
924
Salesforce
CRM
$151B
| $6.45M | 0.01% |
74,502
-1,943
| -3% | -$169K |
|
|
CXO
925
DELISTED
CONCHO RESOURCES INC.
CXO
| $6.45M | 0.01% |
53,047
+41,614
| +364% | +$5.26M |
|
Similar funds
VGA
AQR Capital Management's Q2 2017 Portfolio in Review
As of Q2 2017, AQR Capital Management held 2,306 positions worth $75.6B, up 0.44% from $75.2B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
AQR Capital Management's Q2 2017 filing shows 139 new, 928 increased, 1,013 reduced and 118 closed positions. Its largest new stake was DXC Technology: 2,594,054 shares worth $172M. The largest sale was Wells Fargo, an estimated $236M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Technology and Industrials.
- AQR Capital Management's largest Q2 2017 buy was DXC Technology: 2,594,054 shares worth $172M.
- AQR Capital Management added most to Gilead Sciences in Q2 2017, an estimated $234M increase.
- AQR Capital Management's biggest Q2 2017 reduction was Wells Fargo, cutting an estimated $236M.
- AQR Capital Management fully exited Computer Sciences in Q2 2017, selling an estimated $77.8M.
- AQR Capital Management's ten largest holdings make up 9.2% of its $75.6B portfolio in Q2 2017.
- AQR Capital Management opened 139 new positions and closed 118 in Q2 2017.
- AQR Capital Management's portfolio value rose 0.44% quarter-over-quarter to $75.6B.
Based on AQR Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.